P16 mutations/deletions are not frequent events in prostate cancer

British Journal of Cancer

Volumn 74, Issue 1, 1996, Pages 120-122

  Tamimi, Y ^a   Bringuier, P P ^a   Smit, F ^a   Van Bokhoven, A ^a   Debruyne, F M J ^a   Schalken, J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Mutation; p16; Prostate cancer

Indexed keywords

PROTEIN KINASE INHIBITOR;

ARTICLE; CELL LINE; CHROMOSOME 9P; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENE DELETION; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0030015955     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.325     Document Type: Article

References (20)

1. BERGERHEIM US, KUNIMI K, COLLINS VP AND EKMAN P. (1991). Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chrom. Cancer, 3, 215-220.
2. BOVA GS, CARTER BS, BUSSEMAKERS MJ, EMI M, FUJIWARA Y AND KYPRIANOU N. (1993). Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53, 3869-3873.
3. CAIRNS P, MAO L, MERLO A, LEE DJ, SCHWAB D AND EBY Y. (1994). Rates of p16 (MTS1) mutations in primary tumours with 9p loss (letter; comment). Science, 265, 415-417.
4. CHENG JQ, JHANWAR SC, KLEIN WM, BELL DW, LEE WC AND ALTOMARE DA. (1994). p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res., 54, 5547-5551.
5. DU MANOIR S, SPEICHER MR, JOOS S, SCHROCK E, POPP S AND DOHNER H. (1993). Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum. Genet., 90, 590-610.
6. HANNON GJ AND BEACH D. (1994). p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest (see comments). Nature, 371, 257-261.
7. JACOBY LB, MACCOLLIN M, LOUIS DN, MOHNEY T, RUBIO MP AND PULASKI K. (1994). Exon scanning for mutation of the NF2 gene in schwannomas. Hum. Mol. Genet., 3, 413-419.
8. KAMB A, GRUIS NA, WEAVER FELDHAUS J, LIU Q, HARSHMAN K AND TAVTIGIAN SV. (1994). A cell cycle regulator potentially-involved in genesis of many tumour types (see comments). Science, 264, 436-440.
9. MILLER SA, DYKES DD AND POLESKY HF. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
10. MORI T, MIURA K, AOKI T, NISHIHIRA T, MORI S AND NAKAMURA Y. (1994). Frequent somatic mutation of the MTS1/CDK41 (multiple tumour suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54, 3396-3397.
11. NASMYTH K AND HUNT T. (1993). Cell cycle. Dams and sluices (news; comment). Nature, 366, 634-635.
12. NOBORI T, MIURA K, WU DJ, LOIS A, TAKABAYASHI K AND CARSON DA. (1994). Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756.
13. PHILLIPS SM, BARTON CM, LEE SJ, MORTON DG, WALLACE DM AND LEMOINE NR. (1994). Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br. J. Cancer, 70, 1252-1257.
14. POLYAK K, KATO JY, SOLOMON MJ, SHERR CJ, MASSAGUE J, ROBERTS JM AND KOFF A. (1994). p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Der., 8, 9-22.
15. SERRANO M, HANNON GJ AND BEACH D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/ CDK4 (see comments). Nature. 366, 704-707.
16. SHEFFIELD VC, BECK JS, KWITEK AE, SANDSTROM DW AND STONE EM. (1993). The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics, 16, 325-332.
17. SPRUCK CH, GONZALEZ ZULUETA M, SHIBATA A, SIMONEAU AR, LIN MF AND GONZALES F. (1994). p16 gene in uncultured tumours (letter) (see comments). Nature, 370, 183-184.
18. UEKI K, RUBIO MP, RAMESH V, CORREA KM, RUTTER JL AND VON DEIMLING A. (1994). MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum. Mol. Genet., 3, 1841-1845.
19. VISAKORPI T, KALLIONIEMI AH, SYVANEN AC, HYYTINEN ER, KARHU R AND TAMMELA T. (1995). Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55, 342-347.
20. INK4) in human breast carcinomas. Cancer Res., 54, 5262-5264.